Heart pump study for very severe heart failure
Part of Heart & circulation clinical trials.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Be able to sign consent to join the study
- Have a body size large enough (body surface area at least 1.2 m²)
- Have very weak heart pumping (left ejection fraction 25% or less) and be class IV (severe symptoms even at rest)
- Despite best heart-failure medicines, you must fit at least one “not improving” situation (for example, very poor exercise test results, worsening organ function, or needing heart support/inotrope medicines)
- Not have major exclusion issues like dangerous blood clotting problems, serious infection, very severe lung disease, recent stroke, kidney failure needing dialysis, or high surgical risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This trial tests a heart pump (Corheart 6) for people with severe heart failure who are not getting better with other treatments. It may help if you need a heart assist device.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial looks at how well a small heart pump (Corheart 6 LVAS) works over time for people with severe heart failure that hasn't improved with standard treatments. It aims to help those who need extra support to keep their heart pumping.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Hear when a new Refractory Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.